{"title":"Optimizing strategies in tendon tissue engineering through effective scaffold design: overview of recent advancements.","authors":"Gabrielle Lynn Hamner, Justin Lee Brown","doi":"10.1080/17460751.2026.2672913","DOIUrl":null,"url":null,"abstract":"<p><p>Tendon injuries pose a significant global health challenge due to the poor innate healing capacity of the tissue. Current clinical interventions report limited treatment efficacy, typically resulting in a fibrotic scar that is mechanically inferior to native tissue and predisposed to future re-rupture. Tendon tissue engineering, leveraging advances of biomimetic scaffolds, offers a promising path toward functional regeneration rather than fibrotic repair. The design of these biomimetic scaffolds is a complex, interdisciplinary challenge that has evolved from a simple structural replacement to a sophisticated, bio-instructive strategy. Literature searches were conducted using PubMed, Scopus, and R Discovery with the terms \"tendon tissue engineering scaffold\" or \"tendon regenerative medicine scaffold,\" and studies published between 2020 and 2025 were included. In this review, we outline four key design principles identified to enhance tissue engineering solutions constructed for tendon: 1) Biomechanical compatibility, 2) Biocompatibility and Integration, 3) Porosity and Mass Transport, and 4) Mechanobiological Stimuli. Together, these core parameters mediate the production of hierarchical, bio-instructive scaffolds that integrate cellular components, growth factors, and mechanical stimulation to produce intelligent therapeutic systems for functional, long-lasting tendon regeneration.</p>","PeriodicalId":21043,"journal":{"name":"Regenerative medicine","volume":" ","pages":"337-351"},"PeriodicalIF":3.0000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13271277/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regenerative medicine","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1080/17460751.2026.2672913","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/18 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0
Abstract
Tendon injuries pose a significant global health challenge due to the poor innate healing capacity of the tissue. Current clinical interventions report limited treatment efficacy, typically resulting in a fibrotic scar that is mechanically inferior to native tissue and predisposed to future re-rupture. Tendon tissue engineering, leveraging advances of biomimetic scaffolds, offers a promising path toward functional regeneration rather than fibrotic repair. The design of these biomimetic scaffolds is a complex, interdisciplinary challenge that has evolved from a simple structural replacement to a sophisticated, bio-instructive strategy. Literature searches were conducted using PubMed, Scopus, and R Discovery with the terms "tendon tissue engineering scaffold" or "tendon regenerative medicine scaffold," and studies published between 2020 and 2025 were included. In this review, we outline four key design principles identified to enhance tissue engineering solutions constructed for tendon: 1) Biomechanical compatibility, 2) Biocompatibility and Integration, 3) Porosity and Mass Transport, and 4) Mechanobiological Stimuli. Together, these core parameters mediate the production of hierarchical, bio-instructive scaffolds that integrate cellular components, growth factors, and mechanical stimulation to produce intelligent therapeutic systems for functional, long-lasting tendon regeneration.
期刊介绍:
Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function*. Since 2006, Regenerative Medicine has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine sector. The journal focusses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies – it’s all about regeneration and not a specific platform technology. The journal’s scope encompasses all aspects of the sector ranging from discovery research, through to clinical development, through to commercialization. Regenerative Medicine uniquely supports this important area of biomedical science and healthcare by providing a peer-reviewed journal totally committed to publishing the very best regenerative medicine research, clinical translation and commercialization.
Regenerative Medicine provides a specialist forum to address the important challenges and advances in regenerative medicine, delivering this essential information in concise, clear and attractive article formats – vital to a rapidly growing, multidisciplinary and increasingly time-constrained community.
Despite substantial developments in our knowledge and understanding of regeneration, the field is still in its infancy. However, progress is accelerating. The next few decades will see the discovery and development of transformative therapies for patients, and in some cases, even cures. Regenerative Medicine will continue to provide a critical overview of these advances as they progress, undergo clinical trials, and eventually become mainstream medicine.